Japan approves subcutaneous autoinjector form of Leqembi for Alzheimer's
Go back to Japan approves subcutaneous autoinjector form of Leqembi for Alzheimer's| BARNES GROUP, Inc. (NYSE: B) | Delayed: 40.59 +0.16 (0.40%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $40.43 | 52 Week High | $44.27 | |||
| Open | $40.82 | 52 Week Low | $30.07 | |||
| Day High | $40.88 | P/E | 30.98 | |||
| Day Low | $40.46 | EPS | $1.31 | |||
| Volume | 1,828,954 | |||||
| BIOAMBER, Inc. (NASDAQ: BIOA) | Delayed: 5.52 -0.04 (0.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.56 | 52 Week High | $8.73 | |||
| Open | $5.61 | 52 Week Low | $2.86 | |||
| Day High | $5.70 | P/E | N/A | |||
| Day Low | $5.43 | EPS | $-3.82 | |||
| Volume | 186,230 | |||||



